The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A survey study of prevention and treatment patterns by academic and community oncologists for papulopustular, acneiform skin rash associated with epidermal growth factor receptor inhibitor (EGFRi) therapy.
 
Mario E. Lacouture
Stock and Other Ownership Interests - Oncoderm (I)
Honoraria - Apricity Health; AstraZeneca; Deciphera; Incyte; Innovaderm; Janssen; L'Oreal; La Roche-Posay; Lutris; MJH Associates; Nanology; Novartis; Novocure; OnQuality Pharmaceuticals; RBC consultants; Relay Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Tyra Biosciences
Consulting or Advisory Role - Apricity Health; AstraZeneca; Deciphera; Genentech; Incyte; Innovaderm; Janssen Research & Development; La Roche-Posay; Lutris; Novartis; Novocure; OnQuality Pharmaceuticals; Relay Therapeutics; Roche; Roche; Seagen; Tyra Biosciences
Research Funding - AstraZeneca/MedImmune (Inst); Columbia University (Inst); Lutris; National Jewish Health (Inst); Novartis (Inst); Novocure; Paxman; US Biotest
Other Relationship - Oncoderm (I)
(OPTIONAL) Uncompensated Relationships - Oncoderm
 
Milan J. Anadkat
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Anthem; Bristol-Myers Squibb; Celgene; CVS Health; Dexcom; Gilead Sciences; Humana; Incyte; Johnson & Johnson; Lilly; Medtronic; Merck; Moderna Therapeutics; Moderna Therapeutics (I); Mylan; Perrigo; Pfizer; Procter & Gamble; Quest Diagnostics; Regeneron; Roche; United Health Group; Walgreens Boots Alliance
Honoraria - Abbvie; Adgero Biopharmaceuticals; Boehringer Ingelheim; Innovaderm; Novocure; UCB
Consulting or Advisory Role - Adgero Biopharmaceuticals; Boehringer Ingelheim; Kintara Therapeutics; Novocure
Research Funding - Abbvie (Inst); AnaptysBio (Inst); Biogen (Inst); Boehringer Ingelheim (Inst); InflamRx (Inst); Lilly (Inst); Lutris (Inst); Novartis (Inst); OnQuality Pharmaceuticals (Inst); UCB (Inst); Veloce Pharmaceuticals (Inst); XBiotech (Inst)
 
Anisha B Patel
Consulting or Advisory Role - Deciphera; NanOlogy; Novartis; OnQuality Pharmaceuticals
Research Funding - Lutris (Inst); OnQuality Pharmaceuticals (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; OnQuality Pharmaceuticals
 
Omkar Subhash Marathe
Honoraria - OnQuality Pharmaceuticals
Consulting or Advisory Role - OnQuality Pharmaceuticals
Research Funding - OnQuality Pharmaceuticals
 
Mark L Webb
Employment - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
 
Robert Claude Tyler
Employment - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
 
Liping Chen
Employment - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
 
Chengguang Wu
Employment - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
 
Wenxi Li
Employment - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
 
Juegang Ju
Employment - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
 
Jie Luo
Employment - OnQuality Pharmaceuticals
Leadership - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - OnQuality Pharmaceuticals
Patents, Royalties, Other Intellectual Property - OnQuality Pharmaceuticals; OnQuality Pharmaceuticals (I)
Travel, Accommodations, Expenses - OnQuality Pharmaceuticals
 
Hong Tang
Employment - Astellas Scientific and Medical Affairs Inc; Dendreon; Juno Therapeutics; OnQuality Pharmaceuticals
Leadership - OnQuality Pharmaceuticals
Stock and Other Ownership Interests - Bristol-Myers Squibb; CVS; Salesforce; Teladoc
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Merck; Novartis; Pfizer; UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Caris Life Sciences; Clovis Oncology; Corvus Pharmaceuticals; Eisai; Genentech/Roche; Janssen Oncology; Merck; Modra Pharmaceuticals; Myovant Sciences; on quality; Pfizer; Tolero Pharmaceuticals
Speakers' Bureau - AstraZeneca; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Myovant Sciences; Sanofi; Seattle Genetics/Astellas
Research Funding - Endocyte (Inst); Merck (Inst); Suzhou Kintor Pharmaceuticals (Inst); US Oncology (Inst)
Expert Testimony - Novartis
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bayer/Onyx; Exelixis; Genentech/Roche; Pfizer; Sanofi/Aventis; US Oncology